These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 26902609)

  • 1. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
    Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
    Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
    Lin SC; Gan ZH; Yao Y; Min da L
    PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.
    Tan W; Li Q; Chen K; Su F; Song E; Gong C
    Oncotarget; 2016 Mar; 7(9):10373-85. PubMed ID: 26863572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Liu H; Guo W; Li P; Deng M
    Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
    Vera-Badillo FE; Templeton AJ; de Gouveia P; Diaz-Padilla I; Bedard PL; Al-Mubarak M; Seruga B; Tannock IF; Ocana A; Amir E
    J Natl Cancer Inst; 2014 Jan; 106(1):djt319. PubMed ID: 24273215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
    Xu TP; Shen H; Liu LX; Shu YQ
    Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast.
    Honma N; Saji S; Kurabayashi R; Aida J; Arai T; Horii R; Akiyama F; Iwase T; Harada N; Younes M; Toi M; Takubo K; Sakamoto G
    APMIS; 2008 Oct; 116(10):923-30. PubMed ID: 19132986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ER-α, ER-Β1 and ER-Β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers.
    Zhang H; Zhang Z; Xuan L; Zheng S; Guo L; Zhan Q; Qu X; Zhang B; Wang Y; Wang X; Song Y
    Clin Transl Oncol; 2012 Mar; 14(3):225-31. PubMed ID: 22374427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.
    Yan S; Jiao X; Li K; Li W; Zou H
    Onco Targets Ther; 2015; 8():279-87. PubMed ID: 25674003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
    Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
    Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis.
    Chen Y; Jiang L; Gao B; Cheng ZY; Jin J; Yang KH
    Breast Cancer Res Treat; 2016 Jun; 157(3):517-25. PubMed ID: 27246814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indispensability of chemotherapy in estrogen receptor-negative early breast cancer in elderly women with diabetes mellitus.
    Jia X; Hong Q; Cheng J; Li J; Wang Y; Mo M; Shao Z; Shen Z; Liu G
    Diabetes Technol Ther; 2015 Apr; 17(4):248-54. PubMed ID: 25781236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
    PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E; Paszko Z; Mazur S
    Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.
    Gonzalez-Conchas GA; Rodriguez-Romo L; Hernandez-Barajas D; Gonzalez-Guerrero JF; Rodriguez-Fernandez IA; Verdines-Perez A; Templeton AJ; Ocana A; Seruga B; Tannock IF; Amir E; Vera-Badillo FE
    Cancer Treat Rev; 2018 Jan; 62():1-8. PubMed ID: 29126017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor-beta mRNA is associated with adverse outcome in patients with breast cancer.
    Markey GC; Cullen R; Diggin P; Hill AD; Mc Dermott EW; O'Higgins NJ; Duffy MJ
    Tumour Biol; 2009; 30(4):171-5. PubMed ID: 19738412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.